FIELD: medicine. SUBSTANCE: liniment with zitazonium is applied to mammary gland skin. Treated area is exposed to pulsed or variable magnetic field for 10-15 min. Course of treatment includes 10-12 procedures. Two or three weeks later magnetic laser MILTA is used for treatment. Time of exposure equals 4-10 min. After procedure is completed liniment with zitazonium is applied to mammary gland skin. EFFECT: stable remission, no subsidiary effects. 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING FIBROCYSTIC DISEASE IN GYNAECOLOGIC PATIENTS | 2009 |
|
RU2405598C2 |
| METHOD AND INTRACAVITARY END PIECE FOR TREATING THE PATIENT FOR UTERINE MYOMA AGGRAVATED WITH FIBROUS CYST DISEASE OF THE MAMMARY GLANDS | 2000 |
|
RU2200599C2 |
| METHOD FOR BENIGN BREAST DISEASES TREATMENT | 2017 |
|
RU2641168C1 |
| METHOD FOR TREATING MASTOPATHY | 1995 |
|
RU2101040C1 |
| METHOD FOR TREATING PATIENTS FOR DIFFUSE MASTOPATHY | 2002 |
|
RU2234958C2 |
| METHOD FOR TREATING PATIENTS WITH HORMONALLY DEPENDENT DISEASES | 2005 |
|
RU2297823C1 |
| METHOD OF TREATING PATIENTS WITH HORMONE-DEPENDENT DISEASES | 2008 |
|
RU2391088C2 |
| METHOD OF TREATING POSTOPERATIVE LYMPHOSTASIS FOLLOWING BREAST CANCER SURGERY | 2011 |
|
RU2487741C2 |
| METHOD FOR TREATING UTERINE MYOMA IN COMBINATION WITH MASTOPATHY | 2002 |
|
RU2257921C2 |
| METHOD FOR CORRECTING HORMONAL AND IMMUNE DISORDERS IN PATIENTS WITH HORMONODEPENDENT DISEASES | 2004 |
|
RU2281748C2 |
